Amgen
AMGN
#100
Rank
โ‚ฌ155.94 B
Marketcap
288,79ย โ‚ฌ
Share price
-0.07%
Change (1 day)
25.34%
Change (1 year)

The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.

Revenue for Amgen (AMGN)

Revenue in 2026 (TTM): โ‚ฌ31.77 Billion

According to Amgen's latest financial reports the company's current revenue (TTM ) is โ‚ฌ31.96 Billion. In 2025 the company made a revenue of โ‚ฌ31.28 Billion a decrease over the revenue in the year 2024 that were of โ‚ฌ32.11 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Amgen from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ31.77 B1.57%
2025 โ‚ฌ31.28 B-2.6%
2024 โ‚ฌ32.11 B25.96%
2023 โ‚ฌ25.50 B3.92%
2022 โ‚ฌ24.53 B6.98%
2021 โ‚ฌ22.93 B10.98%
2020 โ‚ฌ20.67 B-0.88%
2019 โ‚ฌ20.85 B0.47%
2018 โ‚ฌ20.75 B9%
2017 โ‚ฌ19.04 B-12.88%
2016 โ‚ฌ21.85 B10.33%
2015 โ‚ฌ19.81 B20.1%
2014 โ‚ฌ16.49 B21.98%
2013 โ‚ฌ13.52 B3.61%
2012 โ‚ฌ13.05 B8.78%
2011 โ‚ฌ11.99 B6.02%
2010 โ‚ฌ11.31 B10.74%
2009 โ‚ฌ10.21 B-4.77%
2008 โ‚ฌ10.73 B6.08%
2007 โ‚ฌ10.11 B-6.44%
2006 โ‚ฌ10.81 B3.05%
2005 โ‚ฌ10.49 B34.92%
2004 โ‚ฌ7.77 B17.19%
2003 โ‚ฌ6.63 B27.46%
2002 โ‚ฌ5.20 B16.18%
2001 โ‚ฌ4.48 B20.96%
2000 โ‚ฌ3.70 B16.37%
1999 โ‚ฌ3.18 B43.01%
1998 โ‚ฌ2.22 B12.64%
1997 โ‚ฌ1.97 B6.71%
1996 โ‚ฌ1.85 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ82.76 B 158.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ54.38 B 70.11%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚ฌ52.53 B 64.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ62.05 B 94.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ8.53 B-73.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ25.28 B-20.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ3.77 B-88.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ41.64 B 30.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ37.93 B 18.66%๐Ÿ‡ฌ๐Ÿ‡ง UK